Clinical findings and diagnosis in genetic prion diseases in Germany

被引:27
|
作者
Krasnianski, Anna [1 ,5 ]
Heinemann, Uta [1 ]
Ponto, Claudia [1 ]
Kortt, Jasmine [1 ]
Kallenberg, Kai [2 ]
Varges, Daniela [1 ]
Schulz-Schaeffer, Walter J. [3 ]
Kretzschmar, Hans A. [4 ]
Zerr, Inga [1 ]
机构
[1] Univ Gottingen, Univ Med Sch, Natl Reference Ctr TSE Surveillance, Dept Neurol, Robert Koch Str 40, D-37075 Gottingen, Germany
[2] Univ Gottingen, Univ Med Sch, Dept Neuroradiol, D-37075 Gottingen, Germany
[3] Univ Gottingen, Univ Med Sch, Dept Neuropathol, D-37075 Gottingen, Germany
[4] Univ Munich, Dept Neuropathol, Munich, Germany
[5] Goethe Univ Frankfurt, Dept Psychiat Psychosomat Med & Psychotherapy, D-60054 Frankfurt, Germany
关键词
Prion disease; Familial CJD; M129V polymorphism; PRNP mutation; CREUTZFELDT-JAKOB-DISEASE; FATAL FAMILIAL INSOMNIA; PHENOTYPIC HETEROGENEITY; 14-3-3; PROTEIN; MUTATION; CLASSIFICATION; CRITERIA; CJD;
D O I
10.1007/s10654-015-0049-y
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
To describe the clinical syndrome and diagnostic tests in patients with genetic prion diseases (gPD) in Germany. Clinical features, MRI, EEG, and CSF markers were studied in 91 patients (28 D178N, 20 E200K, 17 inserts, 13 V210I, 8 P102L, 5 E196K). Dementia (35 %) and ataxia (29 %) were the most common initial symptoms and signs. A wide variety and high frequency of neurological/psychiatric symptoms and signs was found during disease course in all patients independently of the type of the mutation. Psychiatric manifestations were frequent (87 %). Neuropsychological abnormalities were observed in 67 %, and aphasia was the most common disturbance (45 %). In E200K, V210I and D178N patients, visual/oculomotor deficits were followed by ataxia early in the disease. Dementia followed by ataxia at onset was common in patients with insert and E196K mutation. P102L patients had isolated ataxia over a longer time period followed by pyramidal signs. Dementia was present only late in the disease course. All clinical routine tests such as MRI, EEG and CSF tests were less sensitive than in sporadic CJD. We provide the first detailed analysis of clinical signs and symptoms in a large group of patients with gPD. Frequency of clinical symptoms and signs was similar in different mutations in a later disease course, but the sequence of occurrence may be of great diagnostic importance. CSF markers were shown to be more sensitive than MRI and EEG.
引用
收藏
页码:187 / 196
页数:10
相关论文
共 50 条
  • [21] Allelic discrimination of genetic human prion diseases by real-time PCR genotyping
    Calero, Olga
    Hortigueela, Rafael
    Albo, Carmen
    de Pedro-Cuesta, Jesus
    Calero, Miguel
    PRION, 2009, 3 (03) : 146 - 150
  • [22] Diagnostic accuracy of cerebrospinal fluid biomarkers in genetic prion diseases
    Schmitz, Matthias
    Villar-Pique, Anna
    Hermann, Peter
    Escaramis, Georgia
    Calero, Miguel
    Chen, Cao
    Kruse, Niels
    Cramm, Maria
    Golanska, Ewa
    Sikorska, Beata
    Liberski, Pawel P.
    Pocchiari, Maurizio
    Lange, Peter
    Stehmann, Christiane
    Sarros, Shannon
    Marti, Eulalia
    Baldeiras, Ines
    Santana, Isabel
    Zakova, Dana
    Mitrova, Eva
    Dong, Xiao-Ping
    Collins, Steven
    Poleggi, Anna
    Ladogana, Anna
    Mollenhauer, Brit
    Kovacs, Gabor G.
    Geschwind, Michael D.
    Sanchez-Valle, Raquel
    Zerr, Inga
    Llorens, Franc
    BRAIN, 2022, 145 (02) : 700 - 712
  • [23] The Features of Genetic Prion Diseases Based on Chinese Surveillance Program
    Shi, Qi
    Zhou, Wei
    Chen, Cao
    Zhang, Bao-Yun
    Xiao, Kang
    Zhang, Xiu-Chun
    Shen, Xiao-Jing
    Li, Qing
    Deng, Li-Quan
    Dong, Jian-Hua
    Lin, Wen-Qing
    Huang, Pu
    Jiang, Wei-Jia
    Lv, Jie
    Han, Jun
    Dong, Xiao-Ping
    PLOS ONE, 2015, 10 (10):
  • [24] Transgenic mice recapitulate the phenotypic heterogeneity of genetic prion diseases without developing prion infectivity: Role of intracellular PrP retention in neurotoxicity
    Chiesa, Roberto
    Restelli, Elena
    Comerio, Liliana
    Del Gallo, Federico
    Imeri, Luca
    PRION, 2016, 10 (02) : 93 - 102
  • [25] The Prion Diseases
    Brown, Khalilah
    Mastrianni, James A.
    JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY, 2010, 23 (04) : 277 - 298
  • [26] Molecular subtype-specific clinical diagnosis of prion diseases
    Heinernann, Uta
    Krasnianski, Anna
    Meissner, Bettina
    Gloeckner, Sara Friederike
    Kretzschmar, Hans A.
    Zerr, Inga
    VETERINARY MICROBIOLOGY, 2007, 123 (04) : 328 - 335
  • [27] Prion Diseases
    Tee, Boon Lead
    Ibarrola, Erika Mariana Longoria
    Geschwind, Michael D.
    NEUROLOGIC CLINICS, 2018, 36 (04) : 865 - +
  • [28] Molecular biology and pathology of prion strains in sporadic human prion diseases
    Gambetti, Pierluigi
    Cali, Ignazio
    Notari, Silvio
    Kong, Qingzhong
    Zou, Wen-Quan
    Surewicz, Witold K.
    ACTA NEUROPATHOLOGICA, 2011, 121 (01) : 79 - 90
  • [29] Utility of Mass Spectrometry in the Diagnosis of Prion Diseases
    Silva, Christopher J.
    Onisko, Bruce C.
    Dynin, Irina
    Erickson, Melissa L.
    Requena, Jesus R.
    Carter, John Mark
    ANALYTICAL CHEMISTRY, 2011, 83 (05) : 1609 - 1615
  • [30] Human prion diseases in the Czech Republic
    Rohan, Z.
    Rusina, R.
    Maresova, M.
    Matej, R.
    EPIDEMIOLOGIE MIKROBIOLOGIE IMUNOLOGIE, 2015, 64 (03): : 115 - 120